SILO PHARMA, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $52 for the 3-month period ending 2020-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2021-05-17
- SILO PHARMA, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2020-03-31 was $52.00.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|
| 2020-03-31 | $52.00 10-Q · filed 2021-05-17 | |
| 2019-09-30 | $375.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |